Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
The etiological agent of the COVID-19 pandemic is SARS-CoV-2. As a member of the Coronaviridae, the enveloped pathogen has several membrane proteins, of which two, E and 3a, were suggested to function as ion channels. In an effort to increase our treatment options, alongside providing new research t...
Main Authors: | Prabhat Pratap Singh Tomar, Miriam Krugliak, Isaiah T. Arkin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/3/532 |
Similar Items
-
Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library
by: Prabhat Pratap Singh Tomar, et al.
Published: (2021-06-01) -
Potential Viroporin Candidates From Pathogenic Viruses Using Bacteria-Based Bioassays
by: Prabhat Pratap Singh Tomar, et al.
Published: (2019-07-01) -
Role of Calcium Channel Blockers in Myocardial Preconditioning
by: Simonovic Nina, et al.
Published: (2017-12-01) -
Drug-disease interaction: effect of inflammation on the pharmacological response to calcium channel blockers
by: Mahmoud, Sherif
Published: (2010) -
Calcium-channel blockers for the prevention of stroke: from scientific evidences to the clinical practice
by: S. Taddei
Published: (2013-05-01)